Loading clinical trials...
Loading clinical trials...
Women are recognized as being at greater risk of ACL injury, with a risk 6 times higher than that of men. Hyperlaxity is a risk factor for ACL injury, but the pathophysiological basis for this is poor...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT06661122 · Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Low-volume Metastasis
NCT06334120 · Non-metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer
NCT07524270 · Womens Health, Menstrual Symptoms
NCT06925815 · Healthy Pregnant Women, Obese Pregnant Women, and more
CHU Nice - Hôpital de l'Archet 2
Nice, Alpes-Maritimes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions